Clinical trial
Metformin as an Adjunctive Therapy to Catheter Ablation in Atrial Fibrillation
NCT04625946 is registered in ClinicalTrials.gov with University of Michigan as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Metformin as an Adjunctive Therapy to Catheter Ablation in Atrial Fibrillation
- Lead sponsor
- University of Michigan
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- January 19, 2021
- Completion date
- August 10, 2025
- Enrollment
- 117 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.